Meet the rest of the team who equally share a passion for innovation and technology.
Founding PartnerWith over 15 years of experience in venture investment and incubation, Yasu has an impressive track record. He has successfully managed a portfolio of 10 high-tech ventures, including an IPO and 4 M&A deals. Formerly the Deputy General Manager of Mitsui Sumitomo Insurance Venture Capital, Yasu brings strong leadership and organizational development skills to his role as an investor. He has also served as a board director for multiple early-stage companies and has a solid network within Australia’s innovation ecosystem, including partnerships with Austrade, local VC’s, and government schemes like ‘Accelerating Commercialisation’.
General Partner, Representative of New Frontier Capital ManagementShigeki is the CEO of NFCM Hong Kong and Executive VP of NFCM. He represents New Frontier Capital Management with extensive experience as an Investment Committee member for global funds including Cybernaut New Frontier Venture Fund (China VC), CMH Growth Fund (China PE), and Tata Capital Growth Fund I & II (India PE). Previously Head of Investment Department at Mizuho Securities for seven years, Shigeki oversaw the Private Equity fund business. A Corporate Finance, Cross-border M&A, Capital Markets, and PE Fund Management expert, he has approximately 20 years of experience. Shigeki has worked in both the Tokyo and New York offices of the Mizuho group.
Chair of Investment CommitteeDoron is Monash University’s Deputy Vice-Chancellor (Enterprise and Engagement) and Senior Vice-President. Doron has held a range of senior executive roles focused on enterprise, innovation, venture capital and commercialisation, working across a range of sectors including higher education, government and private industry most notably he was the inaugural Vice-President, Enterprise, at the University of Melbourne and before that the founding CEO of Commercialisation Australia. He has personally founded six companies – each focused on the commercialisation of new technology – and has further led and facilitated the creation of several new ventures in partnership with global corporations and institutions. He was the founder and CEO of Prescient Venture Capital, and is currently the Managing Director of Superb Solutions Pty Ltd, which provides strategic consulting and advisory services to the venture capital, start-up and research sectors.
Professor Toby Walsh
Professor Fabio Ramos
John Lee, M.D.
Explore our blog for valuable insights and industry news related to empowering emerging companies and promoting technological innovation.
FIEA Article 63:
本ファンドは金融商品取引法第63条に基づく「適格機関投資家等特例業務」に関する特例の適用を受けています。適格機関投資家等特例業務に関する公衆縦覧【法第63条第６項】はこちらのリンクからご覧頂けます。Form 20-2 [Japan]
For Investors in Japan:
InterValley Ventures Pty Ltd has filed the Notification for Specially Permitted Businesses for Qualified Institutional Investors, etc. (SPBQII) to the Financial Services Agency of Japan pursuant to Article 63 of the Financial Instruments and Exchange Act (FIEA). Public Inspection Regarding Specially Permitted Businesses for Qualified Institutional Investors, etc. [FIEA Article 63(6)] is available at the following link: Form 20-2 [Japan]
This material was created by InterValley Ventures Pty Ltd ACN 620 419 123 (General Partner). InterValley Ventures Pty Ltd is a Corporate Authorised Representative (CAR: 1265243 of Affirmative Financial Services Pty Ltd who holds an Australian Financial Services Licence (AFSL: 331840). This material is for information purposes only and should not be construed as an offer or solicitation or recommendation to buy or sell any financial products. The information in this presentation or communication is directed and available to residents of Australia only deemed to be Wholesale Clients under Section 761G of the Corporations Act of 2001. This material is neither a prospectus nor a disclosure document under the Corporations Act 2001 (Cth) (Act), nor is it required to be. A copy is not required to be, and has not been, lodged with the Australian Securities and Investments Commission. This material has been prepared only for issue to and use by prospective investors who qualify as Wholesale Investors as defined in the Act (Wholesale Investors) and is not intended to be received or read by anyone other than a Wholesale Investor. An interest in AI^Human, LP (Fund) will only be issued to investors that are Wholesale Investors.
Jurisdiction: This material does not constitute, and may not be used for the purpose of, an offer or solicitation in any jurisdiction other than the Commonwealth of Australia or in circumstances in which such offer or solicitation is not authorised other than as set out in the separate international disclosure statement. No recipient of this material in any jurisdiction other than the Commonwealth of Australia may treat it as constituting an invitation to them to apply for an interest in the Fund unless, in the relevant jurisdiction, such an invitation could lawfully be made to that recipient or the Application Form in the separate AI/HUMAN, LP Information Memorandum could lawfully be used in compliance with applicable law.
Confidentiality: This material is the property of the General Partner. By receiving this material, the recipient agrees to keep its content confidential and agrees not to copy, supply, disseminate or disclose any information in relation to its content without the prior written consent of the General Partner.
General advice: This information is intended to be general in nature and is not personal financial product advice. Any advice contained in this document is general advice only and has been prepared without considering your objectives, financial situation or needs. Before acting on any information, you should consider the appropriateness of the information provided and the nature of the relevant financial product having regard to your objectives, financial situation and needs. You should seek independent financial advice and read the relevant disclosure statements or other offer document prior to making an investment decision (including a decision about whether to acquire or continue to hold) about a financial product. The General Partner makes no representation to the recipient or advisers (as relevant) as to, or in relation to, the accuracy or completeness of the information, statements, opinions or matters (express or implied) arising out of, contained in or derived from this material or any omission from this material or of any other written or oral information or opinions provided now or in the future to any interested party or its advisers. In particular, no representation or warranty is given as to the achievement or reasonableness of any plans, future projections, prospects or financial returns and nothing in this material is or should be relied upon as a promise or representation as to the future. The General Partner expressly disclaims all liability for any loss or damage of whatsoever kind (whether foreseeable or not) which may arise from any person acting on any information and opinions relating to the Fund contained in this material or any information which is made available in connection with any further enquiries, notwithstanding any negligence, default or lack of care. In furnishing this material, the General Partner undertakes no obligation to provide any additional information other than as specifically stated in this material.
Forward looking statements: This material contains forward looking statements which are identified by words such as “may”, “could”, “anticipates”, “believes”, “estimates”, “expects”, “intends”, “plans” and other similar words that involve risks and uncertainties. These forward looking statements are subject to various factors that could cause the results of the Fund to differ materially from those expressed or anticipated in these statements. The General Partner does not intend to update or revise forward looking statements, or to publish prospective financial information in the future, regardless of whether new information, future events or any other factors affect the information contained in this material, except where required by law.
Investment risk warning: Investment in the Fund involves a high level of risk and is not suitable for investors who are unable to sustain the loss of all or part of the sum invested, or who require predictable levels of return or liquidity. Section 6 of the separate InterValley AI/HUMAN, LP Information Memorandum sets out additional risks of an investment in the Fund. Potential investors should assess their own appetite for such risks independently and consult their own advisors before making a decision to invest in the Fund. Investment in the Fund should be regarded as speculative and is subject to the conflicts of interest described in the separate Information Memorandum. Investments should be considered only by wholesale investors.